Financial Security Advisor’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,784
Closed -$223K 165
2026
Q1
$223K Buy
2,784
+5
+0.2% +$412 0.04% 151
2025
Q4
$237K Hold
2,779
0.05% 140
2025
Q3
$216K Hold
2,779
0.05% 133
2025
Q2
$217K Hold
2,779
0.05% 123
2025
Q1
$201K Hold
2,779
0.05% 121
2024
Q4
$206K Buy
+2,779
New +$195K 0.05% 114
2024
Q3
Sell
-2,779
Closed -$257K 118
2024
Q2
$257K Hold
2,779
0.09% 89
2024
Q1
$266K Hold
2,779
0.09% 87
2023
Q4
$212K Buy
+2,779
New +$193K 0.08% 92

Other funds holding EW

Financial Security Advisor's EW Position: Q2 2026 in Review

Financial Security Advisor sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 2,784 shares — an estimated $223K sold.

Financial Security Advisor first reported a position in EW in Q4 2023 and held it in 9 quarters. The position peaked at $266K in Q1 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Financial Security Advisor reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Financial Security Advisor sold 2,784 Edwards Lifesciences shares in Q2 2026, an estimated $223K.
  • Financial Security Advisor first reported a position in Edwards Lifesciences in Q4 2023 and held it in 9 quarters.
  • Financial Security Advisor's Edwards Lifesciences position peaked at $266K in Q1 2024.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Financial Security Advisor's 13F filing for Q2 2026, filed 11 Aug 2026.